SCHEMBL3225069

SCHEMBL3225069

CCCCCCCCC(=O)OCC(CC)CCCC

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.93
CYP3A4 P08684 1/20 0.93
ATM Q13315 1/20 0.93
TDP1 Q9NUW8 1/20 0.93
LMNA P02545 2/20 0.65
ALDH1A1 P00352 1/20 0.65
MAPT P10636 1/20 0.62
KDM4E B2RXH2 1/20 0.58
DUSP3 P51452 1/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
RECQL P46063 1/20 0.57
DGKA P23743 1/20 0.56
PRKCA P17252 3/20 0.55
PRKCE Q02156 1/20 0.55
PRKCQ Q04759 1/20 0.55
PRKCD Q05655 1/20 0.55
PRSS1 P07477 1/20 0.54
PRSS2 P07478 1/20 0.54
PRSS3 P35030 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL333274 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA
SCHEMBL333145 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA
SCHEMBL4887025 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA
SCHEMBL153398 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA
SCHEMBL9986005 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA
SCHEMBL4625908 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA
SCHEMBL11412640 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA
SCHEMBL55305 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA
SCHEMBL9229154 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA
SCHEMBL28217622 1.00 TSHR (0.93) TSHRCYP3A4ATMTDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025245480-A1 UVASORB COMPLETE COMPOSITIONS, SYSTEMS AND METHODS 3V SIGMA USA INC. (US) 2025-11-27 WO claimed
US-20250281376-A1 Hair Care Composition CORET JOEL MARCEL (US) 2025-09-11 US claimed
US-20250269034-A1 TOPICAL TETRACYCLINE COMPOSITIONS JOURNEY MEDICAL CORP (US) 2025-08-28 US claimed
EP-4580751-A2 STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS Adora Animal Health Corporation (US) 2025-07-09 EP claimed
US-12303528-B2 Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions ADORA ANIMAL HEALTH CORPORATION (US) 2025-05-20 US claimed
US-20250134875-A1 FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF THIRONA BIO, INC. (US) 2025-05-01 US claimed
WO-2025090562-A1 FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF THIRONA BIO, INC. (US) 2025-05-01 WO claimed
US-12195632-B2 Oil-based inkjet ink RISO KAGAKU CORPORATION (JP) 2025-01-14 US claimed
CN-119015394-A Sulfur-containing compound preparation, and preparation method and application thereof 上海优斐斯生物科技有限公司 2024-11-26 CN claimed
CN-118975941-A Moisturizing cosmetic composition and application thereof 杭州毛戈平科技有限公司 2024-11-19 CN claimed
CN-117357409-A Micron silver skin care product and preparation method and application thereof 鹤山市舒柏雅实业有限公司 2024-01-09 CN claimed
CN-114269816-B Porous cellulose microparticles and process for producing the same 阿诺米拉公司 2023-09-19 CN claimed
US-20230225987-A1 TOPICAL PHARMACEUTICAL COMPOSITIONS Dermavant Sciences GmbH (CH) 2023-07-20 US claimed
CN-116139029-A Water-in-oil type cool itching-relieving ointment and preparation method thereof 广州翀潇生物科技有限公司 2023-05-23 CN claimed
US-20230147697-A1 TOPICAL FORMULATIONS HAVING ENHANCED BIOAVAILABILITY BERG, KARA ANN 2023-05-11 US claimed
US-20220347070-A1 UV-PROTECTIVE COMPOSITIONS AND THEIR USE LANDA LABS 2012 LTD (IL) 2022-11-03 US claimed
CN-114269816-A Porous cellulose microparticles and method for producing same 阿诺米拉公司 2022-04-01 CN claimed
EP-3966277-A1 POROUS CELLULOSE MICROPARTICLES AND METHODS OF MANUFACTURE THEREOF Anomera Inc. (CA) 2022-03-16 EP claimed
EP-3577173-B1 COMPOSITIONS CONTAINING FATTY ACID ESTERS OF VEGETABLE ORIGIN AS SOLVENTS BENESSERE VINCENZO (IT) 2020-12-02 EP claimed
US-20070092466-A1 Compositions and Methods for Treating Hair Loss Using C16-C20 Aromatic Tetrahydro Prostaglandins DUKE UNIVERSITY (US) 2007-04-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250134875-A1 FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF ALK, ACVR1, ACVRL1 TSHR 2332/4885CYP3A4 2980/4885ATM 375/4885
US-20230225987-A1 TOPICAL PHARMACEUTICAL COMPOSITIONS TSLP, SQLE, DHCR7 TSHR 4601/4885CYP3A4 1906/4885ATM 4456/4885
US-20070092466-A1 Compositions and Methods for Treating Hair Loss Using C16-C20 Aromatic Tetrahydro Prostaglandins PTGES, PTGES2, PTGS2 TSHR 4249/4885CYP3A4 2512/4885ATM 4681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.